China Dasheng Biotechnology Company (CDBT) has an overall financial health rating of C with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-05-23.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-05-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-05-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-05-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-05-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-05-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-05-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-04-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-04-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-04-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-04-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
